Latest blog articles
-
Simone Veil passed away on 30 June 2017, just two weeks shy of her 90th birthday. The fact that her funeral was a national ceremony at the Hȏtel des Invalides, and that her remains have been interred in the Panthéon - as one of the four women who have been bestowed with this honour because of their...
-
How do we guarantee access to COVID-19 vaccines and therapies, and secure health-related human rights for all? We’ve heard a string of promises in the race for new vaccines and therapies.
-
It’s been almost a month since the COVID-19 pandemic has drastically changed the way we live and work. Now that we are more used to, in a manner of speaking, the extraordinary measures to curtail the rampant spread of the virus, it’s time to seriously consider, and openly discuss, this crisis’...
-
About 100 British officials will arrive in Brussels today to start the mammoth negotiations on the future relationship between the EU and the UK. The two sides are poles apart. The UK wants regulatory detachment from the EU while the EU insists or regulatory alignment.
-
In European societies, Female Genital Mutilation/Cutting FGM/C is regarded as an alien cultural practice that should not be part of society. It is seen as a barbaric tradition that is associated with refugees and immigrants from African and Muslim States who have brought this custom to Europe.
-
The European Union prides itself for being based on the rule of law. Indeed, the success and longevity of the EU as an integration project can be partly explained by, on the one hand, the willingness of Member States to abide by the obligations that stem from the Treaties and, on the other, the...
-
The Istanbul Convention certainly has the potential to improve the protection and support of battered women. However, much will depend on the implementation by the States parties and the interpretation and assessment of the obligations by the monitoring body.
-
Globally the majority of health-related R&D is invested in medicines with substantial guaranteed returns, yet what is missing is extensive R&D targeted at diseases overwhelmingly prevalent in developing countries. This threatens long-term availability of medicines and treatment options for these...